- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Rebuilder Medical Technologies Fined for Illegally Distributing Skin Condition Drug
Rebuilder Medical Technologies has been fined $10,000 and put on a year long probation after pleading guilty to disturbing an unapproved drug into interstate commerce while lacking federal approval.
Rebuilder Medical Technologies has been fined $10,000 and put on a year long probation after pleading guilty to disturbing an unapproved drug into interstate commerce while lacking federal approval.
According to Pharmaceutical Processing:
U.S. Attorney William J. Ihlenfeld II says the company manufactured and distributed a drug for skin conditions that contained colloidal silver. He continued, stating that drugs containing colloidal silver have not been approved by the U.S. Food and Drug Administration because of concerns over the substance’s lack of effectiveness. There also is a risk of side effects such as skin discoloration.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â